Discontinuation report ERWINASE
Report ID | 129623 |
Drug Identification Number | 02237815 |
Brand name | ERWINASE |
Common or Proper name | Erwinia L-asparaginase |
Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
Market Status | MARKETED |
Active Ingredient(s) | ASPARAGINASE |
Strength(s) | 10000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 3 mL vials |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 0001-01-01 |
Actual discontinuation date | |
Remaining supply date | 2021-02-28 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | A separate communication will be issued regarding the supply of Erwinase by Jazz. |
Health Canada comments | |
Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.